Recombinant Protein Panels for Antibody Cross-Reactivity Testing

Recombinant proteins for antibody cross-reactivity testing help researchers compare binding across species orthologs, related protein-family members, isoforms and selected variants under controlled assay conditions. The most useful panel aligns important variables such as sequence boundaries, expression system, tag position and antigen-presentation format, reducing the chance that construct differences will be mistaken for true cross-reactivity. Beta LifeScience offers a broad recombinant protein catalog covering multiple species, expression systems and tag formats. Researchers can select catalog proteins for initial screening or request semi-custom and custom evaluation when aligned constructs, specialized variants, alternative tags or coordinated multi-protein panels are required.

Search by target and compare the species, expressed sequence, host, tag, purity, formulation and documented activity on each current product page.

Compare Catalog Recombinant Proteins

This article focuses on selecting and purchasing recombinant antigens. For broader explanations of cross-reactivity mechanisms and antibody behavior, see Cross Reactivity in Immunology: Definition, Risks & Benefits and How Do I Know If the Antibody Will Cross-React?.

Featured Recombinant Protein Options for Cross-Reactivity Panels

The following catalog examples show how researchers can combine matched orthologs, compare alternative formats or add assay-ready receptor variants. Review each current product page for the selected construct, pack size and available documentation. Beta LifeScience can also confirm availability, lead time and project-specific requirements before ordering. Pack-size-specific SKUs may include a quantity suffix.

The PD-L1 products provide a comparatively close catalog starting point because all three use C-terminal His formats and overlapping extracellular sequence ranges. They should still be reviewed individually: a one-residue boundary difference, host description, formulation or lot-specific documentation may matter in a sensitive comparison. The OX40L examples serve a different purpose. Their sequence ranges and tags are not aligned, so they should not be treated as a ready-made matched ortholog panel. Researchers can use them as individual purchasing options, introduce appropriate format controls or submit aligned OX40L requirements for feasibility review.

Share the antibody, target list, species, required constructs, assay platform, tag preferences and estimated quantities. Catalog matching and coordinated semi-custom or custom formats can be evaluated before quotation.

Start With the Purchasing Decision

The right panel is the smallest set of proteins that answers the program’s next decision. Before requesting a quote, define whether the study needs to:

• confirm binding to the intended human target;
• select an appropriate mouse, rat or cynomolgus model;
• compare related receptors or other protein-family members;
• assess an isoform, mutation or therapeutic target variant;
• evaluate tag-dependent or assay-orientation effects; or
• screen several coordinated antigens before lead selection.

This decision determines which species and constructs are commercially relevant. It also prevents purchasing a large panel that contains proteins with incompatible domains or presentation formats.

How to Compare Recombinant Proteins Before Ordering

Sequence and domain boundaries

Record the accession number and exact residue range rather than comparing product names alone. Orthologs should include equivalent epitope-containing regions wherever practical. If one antigen contains the complete extracellular domain and another includes only a subdomain, a binding difference cannot confidently be attributed to species. Sequence identity can help prioritize orthologs but does not guarantee antibody binding. A substitution inside a linear or conformational epitope may matter more than several changes elsewhere. Detailed interpretation belongs in the broader antibody cross-reactivity guide; the purchasing task is to document the exact sequence represented by every ordered protein.

Expression system

Expression host can affect folding and post-translational modification. Mammalian-expressed extracellular proteins are often useful candidates for conformational or glycosylation-sensitive epitopes, while bacterial or other formats may suit selected linear epitopes and simpler antigens. Use the expression-host selection guide to compare the available systems against the target biology. For cross-species comparison, matching the host reduces one experimental variable. If matching is not possible, document the difference and consider an additional confirmation format.

Tag, tag position and antigen presentation

His, Fc, GST, FLAG, Avi and other tags can support purification, immobilization or detection, but they may also alter accessibility or create tag-related signal. Compare the tag type, N- or C-terminal position and any linker across the entire panel. The protein tag selection guide can help connect tag choice with the intended platform. For SPR or BLI, a site-specifically biotinylated Avi-tagged protein can support oriented capture on a compatible surface. His-tagged proteins may suit anti-His capture or other validated configurations. Fc-tagged proteins can increase apparent avidity through dimerization and require Fc-matched controls. No single tag is best for every SPR, BLI or ELISA design.

Purity, integrity and documented activity

Review the stated purity method, expected molecular mass, formulation and activity documentation. Numerical EC50 or affinity results apply to the test configuration described on the individual product page; they are not assay-independent guarantees for a new antibody. When comparing lots or species, request the documentation needed for the study and keep handling consistent. Reconstitution concentration, freeze-thaw exposure and storage time can influence protein integrity.

Quick Protein-Selection Checklist

Match the Protein to the Assay Platform

ELISA and multiplex screening

ELISA offers a scalable first screen across orthologs and related antigens. Direct adsorption is simple, while capture formats may provide more consistent orientation. Multiplex bead assays can reduce antibody and sample consumption when several proteins must be evaluated together. Use equivalent antigen loading, format-matched controls and a concentration series to avoid interpreting saturation as equal binding.

SPR and BLI

SPR and BLI can provide concentration-dependent binding and kinetic information. Select a tag compatible with the planned capture surface, then evaluate immobilization density, avidity and regeneration conditions. Important numerical results should be reported with the protein construct and assay orientation.

Cell-based confirmation

Recombinant proteins provide controlled antigen comparisons, while cell-based assays present targets in a more native membrane context. Confirm commercially important positive or negative findings in a suitable cellular format when receptor organization, glycosylation or membrane topology could affect recognition.

Choose a Catalog, Semi-Custom or Custom Route

Semi-custom and custom requests remain subject to technical feasibility. Supplying the complete panel at the beginning allows sequence boundaries, tag placement, host and QC requirements to be reviewed together.

Why Build the Panel Through Beta LifeScience?

Beta LifeScience’s catalog covers recombinant proteins from multiple species and expression systems, with His, Fc, GST, FLAG and other format options available across the wider portfolio. Researchers can combine suitable catalog products for rapid screening and request semi-custom evaluation for requirements such as alternative tags, buffer exchange, endotoxin control, higher concentration, specialized packaging or additional QC. Full-custom protein expression can be evaluated when a new sequence or construct is required.

Submitting the complete target list together allows the technical team to review construct compatibility across the proposed panel before quotation. This does not guarantee that every requested format can be produced, but it creates a clearer route for resolving differences before the assay begins.

Information to Include With a Panel Request

1. Target names, species, accession numbers and residue ranges
2. Antibody format, IgG subclass and available concentration
3. Planned ELISA, SPR, BLI, multiplex or cell-based workflow
4. Required orthologs, family members, isoforms, variants and controls
5. Preferred expression system, tag and tag position
6. Quantity, concentration, formulation and packaging requirements
7. Required purity, endotoxin, activity or other QC documentation
8. Desired delivery schedule and quotation requirements

FAQs

Can I combine catalog proteins from different product families?

Yes, when their sequences and formats suit the intended comparison. Review each product independently and add controls for differences in tag, domain boundary or expression host.

Which tag should I choose for SPR or BLI?

Choose a tag compatible with the capture surface and assay orientation. Avi-biotin, His and Fc formats can each be useful, but immobilization strategy, oligomeric state and controls determine suitability.

Are the listed PD-L1 products a perfectly matched panel?

They are a close catalog starting point, not a claim of perfect equivalence. The human and cynomolgus products list Phe19–Thr239, while the mouse product lists Phe19–Thr238; current formulations and documentation should also be compared.

Can an isoform or variant use semi-custom production?

Potentially. Ask whether the requested sequence can be supported through an established platform. A completely new construct may require full-custom expression.

What should I confirm before ordering?

Confirm the catalog number, sequence, tag, expression system, formulation, pack-size-specific SKU, current availability, documentation and lead time on the live product page or through a written inquiry.

Conclusion

Begin with catalog products whose species, sequence and format match the assay. Where panel members differ, decide whether controls are sufficient or whether aligned production should be evaluated. Sharing the full target list makes it easier to review construct compatibility, route each protein to catalog, semi-custom or full-custom production and prepare an informed quotation.Browse the recombinant protein catalog, then submit specialized orthologs, variants, domains or coordinated panels for technical review.

Submit Your Target List for Technical Evaluation